29.11.21|CTechAccording to the terms of the agreement, the company will retain the primary right to license technologies developed at Ichilov
22.11.18|Meir OrbachThe firm’s new fund, its sixth, will focus on credit loans to pharmaceutical companies planning to go public
17.10.17|Hagar RavetThe firm is looking to invest up to $5 million a year in early-stage Israeli medical startups with a technology compatible with Chinese market needs
More stories in CTech
